/  February 8, 2017

UW CoMotion spinoff Bellwether Bio completes seed funding

Over the last two years, CoMotion at the University of Washington has partnered with Bellwether Bio, a startup focused on improving the accuracy of cell-free DNA diagnostics for cancer and other conditions. These efforts included funding for development of tools to support the innovation, execution of confidentiality agreements to protect the underlying UW-owned intellectual property, and the negotiation of an exclusive licensing agreement.

Bellwether Bio, launched through CoMotion at UW, just completed its seed funding and is currently recruiting scientists with expertise in genomics and computer science to join its team in Seattle.

Click the link to learn more about the news and recruitment. Also see the article in GenomeWeb about this news.